Li K - Search Results

1

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex.

Wang L, Zhang Q, Ye L, Ye X, Yang W, Zhang H, Zhou X, Ren Y, Ma L, Zhang X, Mei C, Xu G, Li K, Luo Y, Jiang L, Lin P, Zhu S, Lang W, Wang Y, Shen C, Han Y, Liu X, Yang H, Lu C, Sun J, Jin J, Tong H. Wang L, et al. Among authors: li k. Br J Cancer. 2023 Feb;128(4):691-701. doi: 10.1038/s41416-022-02074-0. Epub 2022 Dec 8. Br J Cancer. 2023. PMID: 36482192 Free PMC article.

2

Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.

Tong H, Li K, Mei C, Wang H, Chen Z, Jin J. Tong H, et al. Among authors: li k. Ann Hematol. 2011 Dec;90(12):1493-4. doi: 10.1007/s00277-011-1210-7. Epub 2011 Mar 23. Ann Hematol. 2011. PMID: 21431323 No abstract available.

3

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.

Li K, Hu C, Mei C, Ren Z, Vera JC, Zhuang Z, Jin J, Tong H. Li K, et al. J Transl Med. 2014 Jun 12;12:167. doi: 10.1186/1479-5876-12-167. J Transl Med. 2014. PMID: 24923330 Free PMC article.

4

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.

Hu C, Yu M, Ren Y, Li K, Maggio DM, Mei C, Ye L, Wei J, Jin J, Zhuang Z, Tong H. Hu C, et al. Among authors: li k. Sci Rep. 2017 Jun 6;7(1):2894. doi: 10.1038/s41598-017-03058-4. Sci Rep. 2017. PMID: 28588271 Free PMC article.

5

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.

Hu C, Yu M, Ren Y, Li K, Maggio DM, Mei C, Ye L, Wei J, Jin J, Zhuang Z, Tong H. Hu C, et al. Among authors: li k. Sci Rep. 2017 Nov 7;7(1):15260. doi: 10.1038/s41598-017-14858-z. Sci Rep. 2017. PMID: 29116110 Free PMC article.

6

Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation.

Ye P, Pei R, Jin J, Sun J, Li K, Cao J, Zhou D, Lu Y. Ye P, et al. Among authors: li k. Ann Hematol. 2019 Sep;98(9):2073-2080. doi: 10.1007/s00277-019-03723-w. Epub 2019 Jun 14. Ann Hematol. 2019. PMID: 31201514 Clinical Trial.

7

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.

Zhou X, Mei C, Zhang J, Lu Y, Lan J, Lin S, Zhang Y, Kuang Y, Ren Y, Ma L, Wei J, Ye L, Xu W, Li K, Lu C, Jin J, Tong H. Zhou X, et al. Among authors: li k. Hematol Oncol. 2020 Oct;38(4):531-540. doi: 10.1002/hon.2755. Epub 2020 Jun 24. Hematol Oncol. 2020. PMID: 32469434

8

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.

Li K, Chen L, Zhang H, Wang L, Sha K, Du X, Li D, Zheng Z, Pei R, Lu Y, Tong H. Li K, et al. Among authors: li d. Aging (Albany NY). 2021 Apr 23;13(8):11988-12006. doi: 10.18632/aging.202901. Epub 2021 Apr 23. Aging (Albany NY). 2021. PMID: 33891561 Free PMC article.

9

A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation.

Ma L, Liang B, Hu H, Yang W, Lin S, Cao L, Li K, Kuang Y, Shou L, Jin W, Lan J, Ye X, Le J, Lei H, Fu J, Lin Y, Jiang W, Zheng Z, Jiang S, Fu L, Su C, Yin X, Liu L, Qin J, Jin J, Qian S, Ouyang G, Tong H. Ma L, et al. Among authors: li k. Front Oncol. 2022 Jun 27;12:905490. doi: 10.3389/fonc.2022.905490. eCollection 2022. Front Oncol. 2022. PMID: 35832562 Free PMC article.

10

Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.

Ma H, Cui J, Liu Z, Fang W, Lu S, Cao S, Zhang Y, Chen JA, Lu L, Xie Q, Wang Y, Huang Y, Li K, Tong H, Huang J, Lu W. Ma H, et al. Among authors: li k. Oncogene. 2023 Nov;42(45):3331-3343. doi: 10.1038/s41388-023-02848-7. Epub 2023 Sep 26. Oncogene. 2023. PMID: 37752234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,617 results

Search Page

Filters